19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan Jyothsna VisweswaraiahSenior Director, Drug Creation at Seismic Therapeutics, USASpeaker
Profile
Jyothsna is a scientific leader with deep expertise in biologics discovery and engineering and advancing programs from early R&D through to IND enabling studies. She currently heads the Drug Creation department at Seismic Therapeutic.
Agenda Sessions
S-4321, a novel non-depleting bifunctional PD-1:FcγRIIb agonist, for treatment of immune mediated diseases
, 11:00View Session